Change company Symbol lookup
Select an option...
WECMF WeCommerce Holdings Ltd
STX Seagate Technology Holdings PLC
HLAHU Hamilton Lane Alliance Holdings I Inc
GUERF Guerbet SA
BTCM BIT Mining Ltd
ATHE Alterity Therapeutics Ltd
EPR EPR Properties
LUMN Lumen Technologies Inc
SEMR SEMrush Holdings Inc

Based in United Kingdom
Company profile

hVIVO plc, formerly Open Orphan plc, is a United Kingdom-based specialist contract research organization (CRO). The Company is engaged in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. It provides end-to-end early clinical development services to its client base, which includes global biopharma companies. It offers a portfolio of approximately 10+ human challenge models to test a range of infectious and respiratory disease products, challenge agent manufacturing, specialist drug development, and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. It offers additional clinical field trial services, such as patient recruitment and clinical trial site services. It runs challenge studies in from its Whitechapel quarantine clinic, and its QMB clinic with its specialized on-site virology and immunology laboratory.

Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    3:08p ET 09/20/22
  • Last (size)
  • 52-Wk Range
    0.10 - 0.26
  • (12/15/21 - 09/20/22)
  • --
  • Market Cap
  • Shares Outstanding
  • 0.00
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.5
  • --
  • --

Latest News

No articles or videos found.


There are no calendar events for OPORF.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.